Dynamic contrast-enhanced derived cerebral blood volume correlates better with leak correction than with no correction for vascular endothelial growth factor, microvascular density, and grading of astrocytoma

Journal of Computer Assisted Tomography

Volumn 32, Issue 6, 2008, Pages 955-965

  Haris, Mohammad ^a   Husain, Nuzhat ^b   Singh, Anup ^c   Husain, Mazhar ^b   Srivastava, Savita ^b   Srivastava, Chhitiz ^b   Behari, Sanjay ^a   Rathore, Ram Kishore S ^c   Saksena, Sona ^a   Gupta, Rakesh Kumar ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

^c INDIAN INSTITUTE OF TECHNOLOGY KANPUR   (India)

Author keywords

Angiogenesis; Brain tumor; Microvessel density; Perfusion MRI; Vascular endothelial growth factor

Indexed keywords

BLOOD; BLOOD VESSELS; BRAIN; ENDOTHELIAL CELLS; HEMODYNAMICS; MAGNETIC RESONANCE IMAGING; TUMORS;

ANGIOGENESIS; ASTROCYTOMA; BLOOD VOLUMES; BRAIN TUMORS; HIGH GRADES; LOW GRADE; MICROVESSEL DENSITY; PERFUSION INDICES; PERFUSION MRI; VASCULAR ENDOTHELIAL GROWTH FACTOR;

GRADING;

GADOLINIUM PENTETATE; VASCULOTROPIN; CONTRAST MEDIUM; DIAGNOSTIC AGENT; VASCULOTROPIN A;

ANGIOGENESIS; ARTICLE; ASTROCYTOMA; BLOOD BRAIN BARRIER; BRAIN BLOOD VOLUME; BRAIN PERFUSION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MATHEMATICAL COMPUTING; MEMBRANE PERMEABILITY; MICROVESSEL DENSITY; PRIORITY JOURNAL; QUANTITATIVE ASSAY; ADULT; ARTIFACT; BRAIN TUMOR; COMPUTER ASSISTED DIAGNOSIS; EVALUATION; FEMALE; IMAGE ENHANCEMENT; MALE; METABOLISM; METHODOLOGY; MICROCIRCULATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; VASCULARIZATION;

ADULT; ARTIFACTS; ASTROCYTOMA; BRAIN NEOPLASMS; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MICROCIRCULATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 62149124825     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/RCT.0b013e31816200d1     Document Type: Article

References (50)

1. Russell D, Rubinstein L. Tumors of central neuroepithelial origin. In: Rubenstein LJ, ed. Pathology of Tumors of the Nervous System. Baltimore: Williams & Wilkins; 1989:83-350.
2. Zimmerman HM. The pathology of primary brain tumors. Semin Roentgenol. 1984;19:129-138.
3. Atlas SW, Lavi E, Fisher PG. Intraaxial brain tumors. In: Atlas SW, ed. Magnetic Resonance Imaging of Brain and Spine. Philadelphia: Lippincott Williams & Wilkins; 2002:565-693.
4. Burger PC. Malignant astrocytic neoplasms: classification, pathologic anatomy and response to treatment. Semin Oncol. 1986;13:6.
5. Burger PC, Vogel FS, Green SB, et al. Glioblastoma multiforme and anaplastic astrocytoma: pathologic criteria and prognostic implications. Cancer. 1985;56:1106-1111.
6. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol. 2002;29:15-18.
7. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353-364.
8. Carmeliet P, Jain RK. Angiogenesis in cancer and other disease. Nature. 2000;407:249-257.
9. Ferrara N. Vascular endothelial growth factor: molecular and biological aspects. Corr Top Microbiol Immunol. 1990;237:1-30.
10. Ferrara N, Devis-Smith T. The biology of vascular endothelial growth factor. Endocrinol Rev. 1997;18:4-25.
11. Veikkola T, Alitalo K. VEGFs, receptors and angiogenesis. Semin Cancer Biol. 1999;9:211-220.
12. Shweiki D, Neeman M, Itin A, et al. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroid: implications for tumor angiogenesis. Proc Natl Acad Sci U S A. 1995;92:768-772.
13. Jackson A. Imaging microvasculature structure with contrast enhanced MRI. Br J Radiol. 2003;76:159-173.
14. Abdulrauf SI, Edvardsen K, Ho KL, et al. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. J Neurosurg. 1998;88:513-520.
15. Pietsch T, Valter MM, Wolf HK, et al. Expression and distribution of vascular endothelial growth factor protein in human brain tumors. Acta Neuropathol. 1997;93:109-117.
16. Chaudhry IH, O'Donovan DG, Brenchley PEC, et al. Vascular endothelial growth factor expression correlates with tumor grade and vascularity in gliomas. Histopathology. 2001;39:409-415.
17. Barbier EL, Lamalle L, Decorps M. Methodology of brain perfusion imaging. J Magn Reson Imaging. 2001;13:496-520.
18. Sorensen A, Reimer P. Cerebral MR Perfusion Imaging: Principles and Current Applications. Stuttgart: Thieme; 2000:152.
19. Aronen HJ, Glass J, Pardo FS, et al. Echo-planar MR cerebral blood volume mapping of gliomas: clinical utility. Acta Radiol. 1995;36: 520-528.
20. Aronen HJ, Perkio J. Dynamic susceptibility contrast MRI of gliomas. Neuroimag Clin N Am. 2002;12:501-523.
21. Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast enhanced T2*weighted MR imaging. Radiology. 1999;211:791-798.
22. Sugahara T, Korogi Y, Shigematsu Y, et al. Value of dynamic susceptibility contrast magnetic resonance imaging in the evaluation of intracranial tumors. Top Magn Reson Imaging. 1999;10:114-124.
23. Cha S, Knopp EA, Johnson G, et al. Intracranial mass lesions: dynamic contrast enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology. 2002;223:11-29.
24. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology. 1994;19:41-51.
25. Shin JH, Lee HK, Kwun BD, et al. Using relative cerebral blood flow and volume to evaluate the histopathological grade of cerebral gliomas: preliminary results. AJR Am J Roentgenol. 2002;179:783-789.
26. Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol. 2003;24:1989-1998.
27. Cha S, Johnson G, Wadghiri YZ, et al. Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology. Magn Reson Med. 2003;49:848-855.
28. Jackson A. Analysis of Dynamic contrast enhanced MRI. Br J Radiol. 2004;77:154-166.
29. Zhu WP, Li KL, Kamaly-Asl ID, et al. Quantification of endothelial permeability, leakage space, and blood volume in brain tumors using combined T1 and T2* contrast-enhanced dynamic MR imaging. J Magn Reson Imaging. 2000;11:575-585.
30. Singh A, Haris M, Rathore D, et al. Quantification of physiological and hemodynamic indices using t(1) dynamic contrast-enhanced MRI in intracranial mass lesions. J Magn Reson Imaging. 2007;26:871-880.
31. Law M, Yang S, Babb JS, et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol. 2004;25:746-755.
32. Provenzale JM, Wang GR, Brenner T, et al. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol. 2002;178: 711-716.
33. Roberts HC, Roberts TP, Brasch RC, et al. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol. 2000;21:891-899.
34. Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 2002;61: 215-225.
35. Christov C, Adle-Biassette H, Le Guerinel C, et al. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomas. Neuropathol Appl Neurobiol. 1998;24:29-35.
36. Lev MH, Ozsunar Y, Henson JW, et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. AJNR Am J Neuroradiol. 2004;25:214-221.
37. Woods RP, Grafton ST, Watson JD, et al. Automated image registration: I. General methods and intrasubject, intramodality validation. J Comput Assist Tomogr. 1998;22:139-152.
38. Tovi M, Lilja A, Bergström M, et al. Delineation of gliomas with magnetic resonance imaging using Gd-DTPA in comparison with computed tomography and positron emission tomography. Acta Radiol. 1990;31:417-429.
39. Scott JN, Brasher PM, Sevick RJ, et al. How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology. 2002;59:947-949.
40. Barker FG 2nd, Chang SM, Huhn SL, et al. Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors. Cancer. 1997;80:936-941.
41. Brant-Zawadzki M. Pitfalls of contrast-enhanced imaging in the nervous system. Magn Reson Med. 1991;22:243-248.
42. Machein MR, Kullmer J, Fiebich BL, et al. Vascular endothelial growth factor expression, vascular volume, and capillary permeability in human brain tumors. Neurosurgery. 1999;44:732-741.
43. Zhang ZG, Zhang L, Jiang Q, et al. VEGF enhances angiogenesis and promotes blood brain barrier leakage in the ischemic brain. J Clin Invest. 2000;106:829-838.
44. Maia AC Jr, Malheiros SM, da Rocha AJ, et al. MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. AJNR Am J Neuroradiol. 2005;26:777-783.
45. Uchida M, Chen Z, Liu Y, et al. Overexpression of bradykinin type 2 receptors on glioma cells enhances bradykinin-mediated blood-brain tumor barrier permeability increase. Neurol Res. 2002;24:739-774.
46. Chio CC, Baba T, Black KL. Selective blood-tumor barrier disruption by leukotrienes. J Neurosurg. 1992;77:407-410.
47. Black KL, Ningaraj NS. Modulation of tumor capillaries for enhanced drug delivery selectively to brain tumor. Cancer Control. 2004;11: 165-173.
48. Ludemann L, Grieger W, Wurm R, et al. Comparison of dynamic contrast-enhanced MRI with WHO tumor grading of gliomas. Eur Radiol. 2001;11:1231-1241.
49. Hakyemez B, Erdogan C, Ercan I, et al. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Clin Radiol. 2005;60:493-502.
50. Boxerman JL, Schmainda KM, Weisskoff RM. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol. 2006;27:859-867.